Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations

被引:65
作者
Cervera, R. [1 ]
Tektonidou, M. G. [2 ]
Espinosa, G.
Cabral, A. R. [3 ]
Gonzalez, E. B. [4 ]
Erkan, D. [6 ]
Vadya, S. [5 ]
Adrogue, H. E. [7 ]
Solomon, M. [8 ,9 ]
Zandman-Goddard, G. [9 ,10 ]
Shoenfeld, Y. [9 ,11 ,12 ]
机构
[1] Hosp Clin Barcelona, Serv Malalties Autoimmunes, Dept Autoimmune Dis, E-08036 Barcelona, Catalonia, Spain
[2] Natl Tech Univ Athens, Sch Med, Dept Internal Med 1, Athens, Greece
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico
[4] Univ Texas Med Branch, Dept Med, Div Rheumatol, Galveston, TX USA
[5] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA
[6] Cornell Univ, Hosp Special Surg, Barbara Volcker Ctr Women & Rheumat Dis, Weill Med Coll, New York, NY 10021 USA
[7] Methodist Hosp, Transplant Ctr, Houston, TX 77030 USA
[8] Chaim Sheba Med Ctr, Dept Dermatol, IL-52621 Tel Hashomer, Israel
[9] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[10] Wolfson Med Ctr, Dept Med C, Tel Hashomer, Israel
[11] Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel
[12] Chaim Sheba Med Ctr, Zublodovitz Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
关键词
Thrombocytopenia; skin manifestations; antiphospholipid antibodies; LIVEDO-RETICULARIS; ANTICARDIOLIPIN ANTIBODIES; CUTANEOUS MANIFESTATIONS; CLASSIFICATION CRITERIA; ANTIPLATELET AUTOANTIBODIES; CLINICAL-FEATURES; SNEDDON SYNDROME; FOLLOW-UP; DOMAIN-I; THROMBOSIS;
D O I
10.1177/0961203310395052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyze the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations, and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analyzed on thrombocytopenia and skin manifestations, and presents the recommendations elaborated by the Task Force after this analysis. Lupus (2011) 20, 174-181.
引用
收藏
页码:174 / 181
页数:8
相关论文
共 76 条
[1]  
Acland KM, 1999, BRIT J DERMATOL, V140, P131
[2]   PRELIMINARY CLASSIFICATION CRITERIA FOR THE ANTIPHOSPHOLIPID SYNDROME WITHIN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALARCONSEGOVIA, D ;
PEREZVAZQUEZ, ME ;
VILLA, AR ;
DRENKARD, C ;
CABIEDES, J .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 21 (05) :275-286
[3]  
ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P482
[4]   SKIN-LESIONS ASSOCIATED WITH CIRCULATING LUPUS ANTICOAGULANT [J].
ALEGRE, VA ;
GASTINEAU, DA ;
WINKELMANN, RK .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 120 (03) :419-429
[5]  
[Anonymous], 1993, Haematologica, V78, P313
[6]  
Arfors L, 1996, EUR J HAEMATOL, V56, P230
[7]   THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
ORDIROS, J ;
DERKSEN, RHWM ;
MACHIN, SJ ;
BARQUINERO, J ;
OUTT, HH ;
HARRIS, EN ;
VILARDELLTORRES, M ;
HUGHES, GRV .
MEDICINE, 1989, 68 (06) :366-374
[8]  
ASHERSON RA, 1989, BRIT J DERMATOL, V120, P215
[9]   Amputation of digits or limbs in patients with antiphospholipid syndrome [J].
Asherson, Ronald A. ;
Cervera, Ricard ;
Klumb, Evandro ;
Stojanovic, Ljudmila ;
Sarzi-Puttini, Piercarlo ;
Yinh, Janet ;
Bucciarelli, Silvia ;
Espinosa, Gerard ;
Levy, Roger ;
Shoenfeld, Yehuda .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 38 (02) :124-131
[10]   Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS") - Semantic or antisemantic? [J].
Asherson, Ronald A. ;
Ceirvera, Ricard .
AUTOIMMUNITY REVIEWS, 2008, 7 (03) :164-167